A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
National Cancer Institute (NCI)
Hoffmann-La Roche
Genmab
St. Jude Children's Research Hospital
Mayo Clinic
Cancer Research UK
St. Jude Children's Research Hospital
Shattuck Labs, Inc.
RenJi Hospital
National Cancer Institute (NCI)
Checkpoint Therapeutics, Inc.
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Hoffmann-La Roche
City of Hope Medical Center
Fate Therapeutics
Scripps Health
Incyte Corporation
Incyte Corporation
MultiVir, Inc.
Celgene
Pfizer
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Shenzhen BinDeBio Ltd.
University of Southern California
Fred Hutchinson Cancer Center
Daiichi Sankyo
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Celldex Therapeutics
Masonic Cancer Center, University of Minnesota
University of Arizona
Novartis
Mirna Therapeutics, Inc.
Rutgers, The State University of New Jersey
Seagen Inc.
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Altor BioScience
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)